Progress of Rho-associated protein kinase inhibitor in the treatment of glaucoma

Progress of Rho-associated protein kinase inhibitor in the treatment of glaucoma

Glaucoma is a leading cause of irreversible blindness, which is characterized by characteristic optic atrophy and visual field defects. Elevated intraocular pressure(IOP)is a primary risk factor of glaucoma, while the main cause of elevated IOP lies in the increased aqueous outflow resistance in pat...

Full description

Bibliographic Details
Main Authors: Wen-Shi Chen, Na Song, Yu-Qing Zhang, Xue-Jiao Yang, Wei Zhu, Xian Yang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2019-08-01
Series:Guoji Yanke Zazhi
Subjects:
glaucoma
Rho-associated protein kinase inhibitor
trabecular meshwork
therapy
Online Access:http://ies.ijo.cn/cn_publish/2019/8/201908011.pdf

Similar Items

Similar Items